Pharmacy Medical Policy Updates
The following Pharmacy Medical Policy programs will be updated November 1, 2023:
Effective November 1, 2023:
- Jynarque
Effective December 1, 2023:
- Rystiggo
- Continuous Glucose Monitoring Systems (CGM)
- Insulin Pump
- Tezspire
- SA Oncology
- PCSK9 Inhibitors
- Bempedoic Acid
- Cholestasis Pruritis
- Weight Loss Agents
- Zorvye
- IL-4 Inhibitor
- IL-13 Antagonist
- Cibinqo
- Biologic Immunomodulators
Many of our pharmacy medical policies are maintained through our pharmacy benefit manager, Prime Therapeutics.
To find pharmacy medical policies specific to a medication list, please select a medication list at the bottom of our prior authorization page of our website, https://www.bcbsks.com/providers/precertification-prior-authorization.
If you have any questions regarding this newsletter, please contact your BCBSKS provider representative/consultant.